Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;93(10):5726-5728.
doi: 10.1002/jmv.27181. Epub 2021 Jul 14.

N-terminal domain of SARS CoV-2 spike protein mutation associated reduction in effectivity of neutralizing antibody with vaccinated individuals

Yogendra Singh  1 , Neeraj Kumar Fuloria  2 , Shivkanya Fuloria  2 , Vetriselvan Subramaniyan  3 , Dhanalekshmi Unnikrishnan Meenakshi  4 , Srikumar Chakravarthi  3 , Usha Kumari  5 , Navneet Joshi  6 , Gaurav Gupta  7
Affiliations

N-terminal domain of SARS CoV-2 spike protein mutation associated reduction in effectivity of neutralizing antibody with vaccinated individuals

Yogendra Singh et al. J Med Virol. 2021 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflict of interests.

Figures

Figure 1
Figure 1
N‐terminal domain of SARS CoV‐2 Spike (S) protein mutation associated reduction in effectivity of neutralizing antibody with vaccinated individuals and SARS‐CoV‐2‐reactive T cell‐based adoptive cellular immunotherapy of COVID‐19 infection
See this image and copyright information in PMC

References

    1. Wang S, Qiu Z, Hou Y, et al. AXL is a candidate receptor for SARS‐CoV‐2 that promotes infection of pulmonary and bronchial epithelial cells. Cell Res. 2021;31(2):126‐140. - PMC - PubMed
    1. Kwarteng A, Asiedu E, Sylverken AA, Larbi A, Sakyi SA, Asiedu SO. Molecular characterization of interactions between the D614G variant of SARS‐CoV‐2 S‐protein and neutralizing antibodies: A computational approach. Infect Genet Evol. 2021;91:104815. - PMC - PubMed
    1. Li Q, Wu J, Nie J, et al. The impact of mutations in SARS‐CoV‐2 spike on viral infectivity and antigenicity. Cell. 2020;182(5):1284‐1294.e1289. - PMC - PubMed
    1. Ke Z, Oton J, Qu K, et al. Structures and distributions of SARS‐CoV‐2 spike proteins on intact virions. Nature. 2020;588(7838):498‐502. - PMC - PubMed
    1. Hodcroft EB, Domman DB, Snyder DJ, et al. Emergence in late 2020 of multiple lineages of SARS‐CoV‐2 Spike protein variants affecting amino acid position 677. medRxiv. 2021;2021. 10.1101/2021.02.12.21251658 - DOI

MeSH terms

Substances